Press release
Incyte to Report Fourth Quarter and Year-End Financial Results
WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2019 financial results
About this update from Incyte Corporation
[{"type":"text","content":" WILMINGTON, Del.--(BUSINESS WIRE)--\nIncyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2019 financial results conference call and webcast for 8:00 a.m. ET on Thursday, February 13, 2020.\n\n\nThe schedule for the press release and conference call/webcast is as follows:\n\n\n\n\n\nQ4 & YE 2019 Press Release:\n\n\n\n\nFebruary 13, 2020 at 7:00 a.m. ET\n\n\n\n\n\n\nQ4 & YE 2019 Conference Call:\n\n\n\n\nFebruary 13, 2020 at 8:00 a.m. ET\n\n\n\n\n\n\nDomestic Dial-In Number:\n\n\n\n\n877-407-3042\n\n\n\n\n\n\nInternational Dial-In Number:\n\n\n\n\n201-389-0864\n\n\n\n\n\n\nConference ID Number:\n\n\n\n\n13698234\n\n\n\n\n\nIf you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13698234.\n\n\nThe live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for 30 days.\n\n\nAbout Incyte\n\n\nIncyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20200123005007/en/\n\nIncyte Contacts\nMedia\nCatalina Loveman +1 302 498 6171\[email protected]\n\n\nInvestors\nMichael Booth, DPhil +1 302 498 5914\[email protected]\n\nSource: Incyte","length":5548,"tagName":"div"}]